Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
EPNY - As of  05/21/24, 02:53:30 AM:   32 Insider Transactions.

Sector: Unknown    Industry: Business Software & Services
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for EPNY

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2005-10-11 00:00:00.0 E PIPHANY INC EPNY COLUMBIA WANGER ASSET MANAGEMENT LP 0.0% view
S 2005-10-07 00:00:00.0 E PIPHANY INC EPNY MERRILL LYNCH ASSET MANAGEMENT INC 0.0% view
B 2005-09-30 00:00:00.0 E PIPHANY INC EPNY SSA GLOBAL TECHNOLOGIES 100.0% view
B 2005-08-12 00:00:00.0 E PIPHANY INC EPNY SSA GLOBAL TECHNOLOGIES 8.3% view
B 2005-07-25 00:00:00.0 E PIPHANY INC EPNY GALLEON MANAGEMENT L P 5.2% view
B 2005-02-14 00:00:00.0 E PIPHANY INC EPNY SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC 6.49% view
B 2005-02-11 00:00:00.0 E PIPHANY INC EPNY COLUMBIA WANGER ASSET MANAGEMENT LP 11.7% view
B 2005-02-07 00:00:00.0 E PIPHANY INC EPNY WELLS FARGO & CO 6.3% view
B 2020-10-13 14:44:55.0 Akebia Therapeutics AKBA STATE STREET CORP 10.7% view
S 2020-10-09 15:44:44.0 Akebia Therapeutics AKBA BAUPOST GROUP LLC 0.0% view
S 2020-02-13 16:29:45.0 Akebia Therapeutics AKBA BAUPOST GROUP LLC 16.45% view
B 2020-02-13 16:27:28.0 Akebia Therapeutics AKBA Nantahala Capital Management 8.6% view
S 2019-02-14 16:30:49.0 Akebia Therapeutics AKBA ABRAMS CAPITAL MANAGEMENT n/a view
S 2019-01-11 17:05:05.0 Akebia Therapeutics AKBA Satter Muneer A 2.6% view
B 2019-01-09 16:22:07.0 Akebia Therapeutics AKBA BAUPOST GROUP LLC 20.94% view
B 2018-12-21 16:34:17.0 Akebia Therapeutics AKBA Nantahala Capital Management 4.7% view
S 2018-09-26 16:03:45.0 Akebia Therapeutics AKBA Nantahala Capital Management 9.8% view
S 2018-07-03 17:01:03.0 Akebia Therapeutics AKBA Nantahala Capital Management 4.1% view
B 2018-02-12 18:14:56.0 Akebia Therapeutics AKBA BlackRock Inc 8.3% view
S 2018-01-08 11:16:47.0 Akebia Therapeutics AKBA Novartis Bioventures Ltd 4.9% view
B 2017-08-10 16:19:03.0 Akebia Therapeutics AKBA Satter Muneer A 6.48% view
S 2017-05-22 16:07:32.0 Akebia Therapeutics AKBA Vifor Pharma Ltd 9.13% view
S 2017-02-14 14:27:25.0 Akebia Therapeutics AKBA Nantahala Capital Management 2.431% view
B 2017-02-13 13:21:55.0 Akebia Therapeutics AKBA Satter Muneer A 7.0% view
B 2016-02-12 13:29:36.0 Akebia Therapeutics AKBA Satter Muneer A 6.416% view
B 2016-02-12 08:38:28.0 Akebia Therapeutics AKBA Venture Investors Early Stage Fund IV LP 5.5% view
S 2016-01-25 09:51:22.0 Akebia Therapeutics AKBA EAGLE ASSET MANAGEMENT INC 4.2% view
B 2015-11-18 10:27:57.0 Akebia Therapeutics AKBA Novo A 11.31% view
B 2015-06-16 11:09:35.0 Akebia Therapeutics AKBA Novo A 7.8% view
B 2015-02-09 17:20:44.0 Akebia Therapeutics AKBA Venture Investors Early Stage Fund IV LP 6.01% view
B 2014-04-29 16:55:48.0 Akebia Therapeutics AKBA TRIATHLON MEDICAL VENTURES FUND LP 7.5% view
B 2014-03-31 06:28:54.0 Akebia Therapeutics AKBA Novartis Bioventures Ltd 16.81% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.